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The receptor for nitric oxide (NO), NO-sensitive guanylyl
cyclase, plays a key role in diverse physiological processes
like smooth muscle relaxation, inhibition of platelet
aggregation and synaptic plasticity. NO-sensitive guanylyl
cyclase contains a prosthetic heme group serving as NO-
binding site and mediating the several hundred-fold acti-
vation of the enzyme by NO.
Binding of NO to the heme group results in color changes
thereby allowing direct monitoring of ligand binding to
the receptor. In the absence of NO, the heme group dis-
plays an absorbance maximum of 431 nm indicative of a
five-coordinated heme iron with a histidine as axial lig-
and. Binding of NO shifts the absorbance to 399 nm
which has been attributed to rupture of the histidine to
iron bond resulting in a five coordinated nitrosyl-heme.
These spectral changes induced by ligand binding can be
recorded by UV/vis spectroscopy.
In previous studies on NO binding using UV/vis spectros-
copy, the enzyme was handled as a pure NO-binding pro-
tein, i.e. in the absence of its substrate. By monitoring
binding of NO and activation of the enzyme simultane-
ously, we were able to demonstrate that binding of NO in
the absence of the substrate MgGTP did not induce activa-
tion of the enzyme but produced an inactive conforma-
tion indistinguishable from the active enzyme by
spectroscopy. Activation of this already NO-bound spe-
cies required the presence of MgGTP and additional free
NO at the same time. Furthermore, the substrate MgGTP
or the reaction products (Mg + cGMP + pyrophosphate)
altered the NO-binding process itself as they accelerated
the rupture of the histidine to iron bond.
Deactivation of the enzyme is triggered by dissociation of
NO from the prosthetic heme. NO dissociates from the
heme of GC faster than in many other hemoproteins with
half life times ranging from seconds to minutes. NO sen-
sitizers (lead compound YC-1) have been reported to
inhibit deactivation of the enzyme. By using stopped flow
UV/vis spectroscopy, we analyzed whether this inhibition
of deactivation was caused by either stabilization of the
active conformation after NO dissociation or by inhibi-
tion of NO dissociation itself.
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